Mangoceuticals (Mangoceuticals) Change In Payables And Accrued Expense : $1.02 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mangoceuticals Change In Payables And Accrued Expense?

Mangoceuticals's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was $0.91 Mil. It means Mangoceuticals's Accounts Payable & Accrued Expense increased by $0.91 Mil from Dec. 2023 to Mar. 2024 .

Mangoceuticals's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $0.11 Mil. It means Mangoceuticals's Accounts Payable & Accrued Expense increased by $0.11 Mil from Dec. 2022 to Dec. 2023 .

Mangoceuticals Change In Payables And Accrued Expense Historical Data

The historical data trend for Mangoceuticals's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangoceuticals Change In Payables And Accrued Expense Chart

Mangoceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

0.04

0.11

Mangoceuticals Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial					-	0.10	-0.04	0.05	0.91

Mangoceuticals Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.02 Mil.

Mangoceuticals Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Mangoceuticals's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangoceuticals (Mangoceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mangoceuticals Inc (NAS:MGRX) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

15110 N. Dallas Parkway, Suite 600, Dallas, TX, USA, 75248

Website

https://www.mangoceuticals.com

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED product.

Executives

Amanda Elizabeth Hammer	officer: Chief Operating Officer	5128 GADSDEN AVENUE, KELLER TX 76244
Jacob D. Cohen	director, 10 percent owner, officer: CEO	2101 GLENDALE DRIVE, PLANO TX 75023
Tiger Cub Trust	10 percent owner	19 RYDDINGTON PL, DALLAS TX 75230
Kenny Myers	director	5101 ADDISON CIRCLE,, UNIT 401,, ADDISON TX 75001
Lorraine Pamela D'alessio	director	8200 WILSHIRE BLVD, BEVERLY HILLS, CALIFORNIA CA 90211
Eugene M Johnston	officer: CFO	PO BOX 669047, CHARLOTTE NC 28266
Jonathan Arango	director, officer: President, COO and Secretary	15110 DALLAS PARKWAY, SUITE 600, DALLAS TX 75248
Alex P. Hamilton	director	26 LOOP ROAD, BEDFORD NY 10506